Publications
Publications
  • February 2006 (Revised February 2009)
  • Case
  • HBS Case Collection

AIDS in Brazil

By: Rohit Deshpande and Ricardo Reisen de Pinho
  • Format:Print
  • | Pages:4
ShareBar

Abstract

Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra.

Keywords

Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil

Citation

Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)

About The Author

Rohit Deshpande

Marketing
More Publications

More from the Authors